Fennec Pharmaceuticals (FENC) Payables: 2011-2025
Historic Payables for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to $5.9 million.
- Fennec Pharmaceuticals' Payables rose 51.69% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 17.53%. This contributed to the annual value of $3.2 million for FY2024, which is 14.21% down from last year.
- As of Q3 2025, Fennec Pharmaceuticals' Payables stood at $5.9 million, which was down 1.26% from $5.9 million recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' Payables registered a high of $5.9 million during Q2 2025, and its lowest value of $677,000 during Q2 2021.
- Moreover, its 3-year median value for Payables was $3.9 million (2024), whereas its average is $4.2 million.
- Per our database at Business Quant, Fennec Pharmaceuticals' Payables crashed by 75.43% in 2021 and then surged by 157.46% in 2022.
- Over the past 5 years, Fennec Pharmaceuticals' Payables (Quarterly) stood at $1.2 million in 2021, then spiked by 119.50% to $2.4 million in 2022, then surged by 58.08% to $3.8 million in 2023, then dropped by 14.21% to $3.2 million in 2024, then skyrocketed by 51.69% to $5.9 million in 2025.
- Its Payables was $5.9 million in Q3 2025, compared to $5.9 million in Q2 2025 and $5.3 million in Q1 2025.